Form 8-K Nuveen Churchill Private For: Oct 04
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 4, 2022
Nuveen Churchill Private Capital Income Fund
(Exact name of registrant as specified in its charter)
Delaware | 000-56412 | 88-6187397 | ||||||||||||
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
430 Park Avenue, 14th Floor, New York, NY | 10022 | |||||||
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (212) 207-2003
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
None | N/A | N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☑
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement
On October 4, 2022, NCPIF SPV I, LLC (“SPV I”), a wholly-owned subsidiary of Nuveen Churchill Private Capital Income Fund (the “Company”), entered into Amendment No. 1 to Credit Agreement (the “Amendment”), amending the Credit Agreement, dated as of April 19, 2022 (as amended by the Amendment, the “Credit Agreement”), by and among SPV I, as the borrower, the lenders party thereto, Bank of America, N.A., as administrative agent, the Company, as servicer, U.S. Bank Trust Company, National Association, as collateral administrator (in such capacity, the “Collateral Administrator”) and U.S. Bank National Association, as collateral custodian, relating to the revolving credit facility (the “Facility”).
The Amendment, among other things: (i) increases the maximum amount available under the Facility from $200 million to $250 million; and (ii) increases the rate to be paid from Daily SOFR +2.00 to Daily SOFR +2.15 with a “step up” on the one year anniversary of the Closing Date (as defined therein) increasing from Daily SOFR +2.15 to Daily SOFR +2.40, as reflected in that certain Amendment No. 1 to Credit Agreement. Advances under the Credit Agreement are secured by a pool of broadly-syndicated and middle-market loans subject to eligibility criteria and advance rates specified in the Credit Agreement. Advances under the Credit Agreement may be prepaid and reborrowed at any time during the Availability Period (as defined therein), and SPV I may terminate or reduce the facility amount subject to certain conditions.
The description above is only a summary of the material provisions of the Amendment and is qualified in its entirety by reference to the copy of the Amendment, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference thereto.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The information provided in Item 1.01 of this current report on Form 8-K is incorporated by reference into this Item 2.03.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Nuveen Churchill Private Capital Income Fund | |||||||||||
Date: October 6, 2022 | By: | /s/ Kenneth J. Kencel | |||||||||
Kenneth J. Kencel Chief Executive Officer and President |
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Spearheading the New Era of Water Purification: ANGEL Space Master Series New Product Launch Event Held Successfully
- Stuart Therapeutics, Inc. Announces Upcoming Presentations at ARVO 2024
- A New Therapeutic Target for Traumatic Brain Injury
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!